Hypoxia-induced hyperexcitability in vivo and in vitro in the immature hippocampus

Epilepsy Research

Volumn 26, Issue 1, 1996, Pages 131-140

  Jensen, Frances E ^a   Wang, Carl ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

asphyxia; epilepsy; glutamate; ischemia; neonatal; temporal lobe epilepsy

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; DIZOCILPINE; LORAZEPAM;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; HIPPOCAMPUS; HYPOXIA; NEWBORN; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RAT; TEMPORAL LOBE EPILEPSY;

AGE FACTORS; ANIMALS; ANOXIA; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; ELECTROENCEPHALOGRAPHY; ELECTROPHYSIOLOGY; EPILEPSY, TEMPORAL LOBE; HIPPOCAMPUS; LORAZEPAM; QUINOXALINES; RATS;

EID: 0030550267     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(96)00049-6     Document Type: Conference Paper

References (72)

1. [1] Aicardi, J. and Chevrie, J.J., Convulsive status epilepticus in infants and children. A study of 239 cases, Epilepsia, 11 (1970) 187-197.
2. [2] Hauser, W.A., Annegers, J.F. and Kurland, L.T., Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984, Epilepsia. 34 (1993) 453-468.
3. [3] Volpe, J.J., Neurology of the Newborn, 3rd Ed., W.B. Saunders, Philadelphia, 1994.
4. [4] Volpe, J.J., Neonatal seizures, Pediatrics, 84 (1989) 422-428.
5. [5] Bernes, S.M. and Kaplan, A.M., Evolution of neonatal seizures, Pediatr. Clin. North Am., 41 (1994) 1069-1104.
6. [6] Bergamasco, B., Penna, P., Ferrero, P. and Gavinelli, R., Neonatal hypoxia and epileptic risk: A clinical prospective study, Epilepsia, 25 (1984) 131-146.
7. [7] Bergman, I., Painter, M.J. and Hirsch, R.P., Outcome in neonates with convulsion treated in an intensive care unit, Ann. Neurol., 14 (1983) 642-647.
8. [8] Scher, M.S., Aso, K., Beggarly, M.E., Hamid, M.Y.. Steppe, D.A. and Painter, M.J., Electrographic seizures in preterm and full-term neonates: Clinical correlates, associated brain lesions, and risk for neurologic sequelae. Pediatrics, 91 (1993) 128-134.
9. [9] Rose, A.L. and Lombroso, C.T., A study of clinical, pathological, and electroencephalopgraphic features in 137 full-term babies with a long term followup, Pediatrics, 45 (1970) 404-425.
10. [10] Connell, J., Oozeer, R. and De Vries, L., Continuous EEG monitoring of neonatal seizures: Diagnostic and prognostic considerations. Arch. Dis. Child., 64 (1989) 459-464.
11. [11] Liu, Z., Mikati, M. and Holmes, G.L., Mesial temporal sclerosis: Pathogenesis and significance, Pediatr. Neurol., 12 (1995) 5-16.
12. [12] Jensen, F.E., Applegate, C.D., Holtzman, D., Belin, T. and Burchfiel, J., Epileptogenic effects of hypoxia on immature rodent brain. Ann. Neurol., 29(6) (1991) 629-637.
13. [13] Jensen, F.E., Applegate, C.D., Burchfiel, J.L. and Lombroso, C.T., Differential effects of perinatal hypoxia and anoxia on long term in seizure susceptibility in the rat, Life Sci., 49(5) (1991) 399-407.
14. [14] Jensen, F.E., Holmes, G.H., Lombroso, C.T., Blume, H. and Firkusny, I., Age dependent long term changes in seizure susceptibility and neurobehavior following hypoxia in the rat, Epilepsia, 33(6) (1992) 971-980.
15. [15] Jensen, F.E., Blume, H., Alvarado, S., Firkusny, I.R. and Geary, C., NBQX blocks the acute and late epileptogenic effects of perinatal hypoxia, Epilepsia, 36(10) (1995) 966-972.
16. [16] Jensen, P.E., Firkusny, I. and Mower, G., Differences in c-fos immunoreactivity due to age and mode of seizure induction, Mol. Brain Res., 17 (1993) 185-193.
17. [17] Liu, Z., Holmes, G.L., Mikati, M., Lombroso, C.T. and Jensen, F.E., Topographic study of electroencephalographic seizures following hypoxia in immature rats, Soc. Neurosci. Abstr., 20 (1994) 396, abstract.
18. [18] Aruffo, C., Ferszt, R., Hildebrandt, A.G. and Cervox-Nararro, J., In vitro neuronal plasticity triggered by subtoxic doses of monosodium glutamate, Clin. Biol. Res., 253 (1987) 229-237.
19. [19] Cline, H.T., Constantine-Paton M. NMDA receptor antagonists disrupt the retionotectal topographic map, Neuron, 3 (1989) 413-426.
20. [20] Pearce, I.A., Cambray-Deakin, M.A. and Burgoyne, R.D., Glutamate acting on NMDA receptors stimulates neurite outgrowth from cerebellar granule cells, FEBS Lett., 223 (1987) 143-147.
21. [21] Collingridge, G.L. and Singer, W., Excitatory amino acid receptors and synaptic plasticity, Trends Pharmacol. Sci., 11 (1990) 290-296.
22. [22] Harris, G.W., Ganong, A.H. and Cotman, C.W., Long term potentiation in the hippocampus involves activation of the NMDA receptors, Brain Res., 323 (1984) 132-137.
23. [23] Baudry, M. and Davis, J.L., Long Term Potentiation: A Debate of Current Issues, MIT Press, Cambridge, 1991.
24. [24] Kleinschmidt, A., Bear, M.F. and Winger, W., Blockage of NMDA receptors disrupts experience-dependent plasticity of kitten striate cortex, Science, 238 (1987) 355-358.
25. [25] Choi, D.W. and Rothman, S.N., The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death, Ann. Rev. Neurosci., 12 (1990) 171-182.
26. [26] Meldrum, B.S., The role of glutamate in epilepsy and other CNS disorders, Neurology, 44(Suppl. 8) (1994) S14-S23.
27. [27] Hollman, M. and Heinemann, S., Cloned glutamate receptors, Ann. Rev. Neurosci., 17 (1994) 31-108.
28. [28] Hattori, H., Morin, A.M., Schwartz, P.H., Fujikawa, D.G. and Wasterlain, C.G., Posthypoxic treatment with MK-801 reduces hypoxic-ischemic damage in the neonatal rat. Neurology, 39(5) (1989) 713-718.
29. [29] McDonald, J.W., Silverstein, F.S., Cardona, D., Hudson, C., Chen, R. and Johnston, M.V., Systemic administration of MK-801 protects against N-methyl-D-aspartate-neurotoxicity in perinatal rats, Neuroscience, 36 (1990) 589-599.
30. [30] McDonald, J.W. and Johnston, M.V., Physiological and pathophysiological roles of excitatory amino acids during central nervous system development, Brain Res. Brain Res. Rev., 15(1) (1990) 41-70.
31. [31] Olney, J.W., Labnuyere, J., Wang, G., Wozniak, D.F., Price, M.T. and Sesma, M.A., NMDA antagonist neurotoxicity: Mechanism and prevention. Science, 254 (1991) 1515-1518.
32. [32] Meldrum, B. and Garthwaite, J., Excitatory amino acid neurotoxicity and neurodegenerative disease, Trends Pharmacol. Sci, 11 (1990) 379-387.
33. [33] Rogawski, M., The NMDA receptor, NMDA antagonists and epilepsy therapy: A status report, Drugs, 44 (1992) 279-292.
34. [34] Scherwin, A.L. and Val Gelder, N.M., Amino acid and catecholamine markers of metabolic abnormalities in human focal epilepsy. In: A.V. Delgado-Escueta, A.A. Ward, Jr., D.M. Woodbury and R.J. Porter (Eds.), Advances in Neurology, Raven Press, New York, 1994, pp. 1011-1032.
35. [35] Nellgard, B. and Weiloch, T., Postischemic blockade of AMPA receptors but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia, J. Cereb. Blood Flow Metab., 12(1) (1992) 2-11.
36. [36] Ginsberg, M.D., Emerging strategies for the treatment of ischemic brain injury. In: S.G. Waxman (Ed.), Molecular and Cellular Approaches in the Treatment of Neurological Disease, Raven Press, New York, 1993, pp. 207-237.
37. [37] Thompson, A.M. and West, D.C., N-methyl-D-aspartate receptors mediate epileptiform activity evoked in some, but not all, conditions in rat neocortical slices. Neuroscience, 19 (1986) 1161-1177.
38. [38] Romijn, H.J., At what age is the developing cerebral cortex of the rat comparable to that of the full-term newborn human baby?, Early Hum. Dev., 26 (1991) 61-67.
39. [39] Vanier, M.T., Holm, M., Ohman, R. and Svennerholm, L., Developmental profiles of gangliosides in human and rat brain, J. Neurochem., 18 (1971) 581-592.
40. [40] Mares, P., Maresova, D. and Schickova, R., Effect of antiepileptic drugs on metrazol convulsions during ontogenesis in the rat, Physiol. Bohemoslov., 30 (1981) 113-121.
41. [41] Kawasaki, K., Traynelis, S.F. and Dingledine, R., Different responses of CA1 and CA3 regions to hypoxia in rat hippocampal slice, J. Neurophysiol, 63 (1990) 385-394.
42. [42] Romijin, H.J., Hofman, M.A. and Gransberger, A., At what age is the developing cerebral cortex of the rat comparable to that of the full term newborn baby?, Early Hum. Dev., 26 (1991) 61-67.
43. [43] Rorke, L.B. and Riggs, H.E., Myelination of the Brain in the Newborn, Lippincott, Philadelphia, 1969.
44. [44] Insel, T.R., Miller, L. and Gelhard, R.E., The ontogeny of excitatory amino acid in the rat forebrain I: N-methyl-D-aspartate and quisqualate receptors, Neuroscience, 35 (1990) 31-43.
45. [45] Ikonomidou, C., Mosinger, J.L., Shahid Salles, K., Labryere, J. and Olney, J.W., Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methylaspartate toxicity, J. Neurosci., 9(8) (1989) 2809-2818.
46. [46] McDonald, J.W., Trescher, W.H. and Johnston, M.V., Susceptibility of brain to AMPA induced excitotoxicity transiently peaks during early postnatal development, Brain Res., 583(1-2) (1992) 54-70.
47. [47] Thurber, S.J., Holmes, G., Stafstrom, C., Jensen, F. and Mikati, M., An ontogenetic study of the behavioral and electrocephalographic effects of quisqualic acid, Epilepsia, (1994), in press.
48. [48] Mattson, M., Neurotransmitters in the regulation of neuronal cytoarchitecture, Brain Res. Rev., 13 (1988) 179-212.
49. [49] Rauschecker, J. and Hahn, S., Ketamine-xylazine anaesthesia blocks consolidation of ocular dominance changes in kitten visual cortex, Nature (London), 326 (1987) 183-185.
50. [50] Pollard, H., Transient expression of the NR2C subunit of the NMDA receptor in developing rat brain, Neuroreport, 4 (1993) 411-414.
51. [51] Monyer, H., Burnashev, N., Laurie, D.J., Sakmann, B. and Seeburg, P.H., Developmental and regional expression in the rat brain and functional properties of four NMDA receptors, Neuron, 12 (1994) 529-540.
52. [52] Ben-Ari, Y., Cherubini, E. and Krnjevic, K., Changes in voltage dependence of NMDA currents during development, Neurosci. Lett., 94 (1988) 88-92.
53. [53] Monyer, H., Sprengel, R. and Schoepfer, R. et al., Heteromic NMDA receptors: Molecular and functional distinction of subtypes, Science, 256 (1992) 1217-1221.
54. [54] Bowe, M.A. and Nadler, J.V., Developmental increase in the sensitivity to magnesium of NMDA receptors on CA1 hippocampal pyramidal cells, Dev. Brain Res., 56 (1990) 55-61.
55. 2+-permeable kainate/AMPA receptors more abundant in immature brain?, Neurosci. Lett., 144 (1992) 65-69.
56. [56] Durand, G.M. and Zukin, R.S., Developmental regulation of RNAs encoding rat brain kainate/AMPA receptors: A northern analysis study, J. Neurochem., 61 (1993) 2239-2246.
57. [57] Burnashev, N., Monyer, H., Seeberg, P.H. and Sakman, B., Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit, Neuron, 8 (1992) 189-198.
58. [58] Swann, J.W., Brady, R.J. and Martin, D.L., Postnatal development of GABA-mediated synaptic inhibition in rat hippocampus, Neuroscience, 28(3) (1989) 551-561.
59. [59] Michelson, H.B. and Lothman, E.W., An in vivo electrophysiological study of the ontogeny of excitatory and inhibitory processes in the rat hippocampus, Dev. Brain Res., 47 (1989) 113-122.
60. A and B-mediated inhibition in the CA3 hippocampal region in the rat, J. Neurobiol, 26(3) (1995) 339-349.
61. [61] Coyle, J.T. and Enna, S.J., Neurochemical aspects of the ontogenesis of GABAergic neurons in the rat brain, Brain Res., 111 (1976) 119-133.
62. [62] Palacios, J.M., Niehoff, D.L. and Kuhar, M.J., Ontogeny of GABA and benzodiazepine receptors: Effects of Triton X-100-bromide and muscimol, Brain Res., 179 (1979) 390-395.
63. A-mediated synaptic events in rat hippocampal CA3 neurons, Eur. J. Neurosci., 6 (1994) 805-813.
64. [64] Cherubini, E., Gaiarsa, J. and Ben-Ari, Y., GABA: An excitatory transmitter in early postnatal life, Trends Neurosci., 14(12) (1991) 515-519.
65. [65] Wasterlain, C.G., Hattori, H. and Yang, C. et al., Selective vulnerability of neuronal subpopulations during ontogeny reflects discrete molecular events associated with normal brain development. In: C.G. Wasterlain and P. Vert (Eds.), Neonatal Seizures, Raven Press, New York, 1991.
66. [66] Bickler, P.E., Gallego, S.M. and Hansen, B.M., Developmental changes in intracellular calcium regulation in rat cerebral cortex during hypoxia, J. Cereb. Blood Flow Metab., 13 (1993) 811-819.
67. [67] Hanson, A.J., Extracellular potassium concentration in juvenile and adult rat brain cortex during anoxia, Acta Physiol. Scand., 99 (1977) 412-420.
68. [68] Haglund, M.M. and Schwartzkroin, P.A., Role of NA,K pump potassium regulation and IPSPs in seizures and spreading depression in immature hippocampal slices, J. Neurophysiol., 63(2) (1990) 225-239.
69. [69] Jensen, F.E., Tsuji, M., Offut, M., Firkusny, I.R. and Holtzman, D., Age dependent effects of hypoxia on high energy phosphate concentrations and pH in the rat brain, Dev. Brain Res., (1993).
70. [70] Michaels, R. and Rothman, S., Glutamate toxicity in vitro: Antagonist pharmacology and intracellular calcium concentrations, J. Neurosci., 10 (1990) 283-292.
71. [71] Dubinsky, J.M. and Rothman, S.M., Intracellular calcium concentrations during 'chemical hypoxia' and excitotoxic neuronal injury, J. Neurosci., 11 (1991) 2545-2551.
72. [72] Choi, D.W., Glutamate neurotoxicity and diseases of the nervous system. Neuron, 1(8) (1988) 623-634.